-
-
-
-
-
-
-
Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
-
-
-
-
-
-
-
Abbott (ABT) call put ratio 1 call to 1.3 puts into quarter results
-
-
-
-
-
-
-
Abbott study finds diabetic ketoacidosis often goes unrecognized
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $130 at RBC Capital
-
-
-
-
-
-
-
Leerink Partners on Abbott Labs (ABT): U.S. MedTech softness could be viewed unfavorably
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Abbott Labs (ABT) on DD Medical Device Growth Sustainability
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $119 at Leerink Partners
-
458,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

